There has been concern in recent years regarding cardiovascular risk in patients using azithromycin which I discussed in an earlier post found here.
A recent study in JAMA further examined cardiovascular risk and mortality in a retrospective review of more than 60,000 patients in the VA Health System. This study specifically identified patients with a diagnosis of pneumonia who were treated with antibiotics including azithromycin compared to other guideline-concordant antibiotics. Their outcomes of measure were 30-day mortality, 90-day mortality, any cardiovascular event, myocardial infarction, heart failure, or cardiac arrhythmias. The mean patient age was 78 years old and comorbid conditions were fairly common (35% with diabetes, 52% with COPD, 26% with heart failure).
Both 30- and 90-day mortality were lower in the azithromycin users (OR 0.76 and 0.73, p<0.001). There was a statistically significant increased odds of myocardial infaraction in the azithromycin group but there was no difference when looking at overall cardiac events, arrhythmias, or heart failure.
This study reinforces the net benefit of azithromycin in patients diagnosed with pneumonia and should allay concerns raised by the recent FDA warnings. But of course, make sure to practice appropriate prescribing and only prescribe antibiotics where they are clinically warranted.
References:
Mortensen EM, Halm EA, Pugh MJ, et al. Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. JAMA 2014;311(21):2199-208.
photo by vandalog
HughesMedicine - Pharmacotherapy Pearls from the Internal Medicine Clinical Pharmacist
Subscribe to:
Post Comments (Atom)
Recommended for you
-
Let’s start with a patient case. A patient is being treated with methylprednisolone 20 mg IV q6 hours for some inflammatory process and...
-
There are many different insulin preparations and supplies available in order to create individualized regimens for patients. Here are s...
-
A 48 year old male is admitted to the hospital after experiencing a fever and malaise for several days. He states that he has some shortn...
-
Let’s start with a patient scenario. A patient presents to the emergency room experiencing a heart failure exacerbation. When entering th...
-
Let's start with a patient case. A patient on hemodialysis (M/W/F) is admitted to the hospital with cellulitis who also meets sepsi...
-
Let’s start with a patient case. An elderly patient is admitted through the emergency department with markedly worsening dyspnea and pu...
-
A 55 year old business executive is being discharged from the hospital after a brief admission for cellulitis. His only PMH is HTN and o...
-
Several previous discussions have dealt with the concept of the minimum inhibitory concentration (MIC) such as extended-infusion piperacil...
-
An earlier post discussed how to bridge argatroban to warfarin in patients with HIT but didn't cover how to determine the likelihood...
-
Let's start with a patient case. A 70 year old male patient is admitted to the hospital for a diabetic foot infection. He has a past...

Azithromycin is one of the most widely used antibiotics in clinical practice. More than 50 million prescriptions are issued in the United States annually, typically for respiratory tract and sexually transmitted infections. It's shocking to know about cardiovascular risk in patients using azithromycin.
ReplyDelete